|
US2735225A
(en)
|
|
1956-02-21 |
|
Table ix p petri dish tests with x-phthalimido- |
|
DE2253251A1
(de)
*
|
1972-10-30 |
1974-05-09 |
Thomae Gmbh Dr K |
Neue phthalimido-sulfonylharnstoffe
|
|
DE3474547D1
(en)
*
|
1983-12-02 |
1988-11-17 |
Shell Int Research |
Diphenyl ether herbicides
|
|
FR2659327A1
(fr)
|
1990-03-08 |
1991-09-13 |
Centre Nat Rech Scient |
Derives du benzisothiazolinone-1-dioxyde, utilisables comme inhibiteurs des elastases.
|
|
US5350761A
(en)
*
|
1991-07-30 |
1994-09-27 |
Ciba-Geigy Corporation |
Indolyl substituted hydroxylamine derivatives
|
|
US5334600A
(en)
*
|
1991-07-30 |
1994-08-02 |
Ciba-Geigy Corporation |
Isoquinolyl substituted hydroxylamine derivatives
|
|
EP0526402B1
(en)
*
|
1991-07-30 |
1998-01-21 |
Novartis AG |
Heteroaryl substituted hydroxylamine derivatives as lipoxygenase inhibitors
|
|
TW219935B
(enExample)
*
|
1991-12-25 |
1994-02-01 |
Mitsubishi Chemicals Co Ltd |
|
|
US5599811A
(en)
*
|
1995-02-21 |
1997-02-04 |
Warner-Lambert Company |
Benzothiazine dioxides as endothelin antagonists
|
|
HUP9902455A3
(en)
|
1996-03-29 |
2000-06-28 |
Pfizer |
6-phenylpyridyl-2-amine derivatives, pharmaceutical compositions containing them
|
|
US6716836B2
(en)
*
|
2001-03-22 |
2004-04-06 |
Boehringer Ingelheim (Canada) Ltd. |
Non-nucleoside reverse transcriptase inhibitors
|
|
GB0124627D0
(en)
*
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
|
DE10348022A1
(de)
*
|
2003-10-15 |
2005-05-25 |
Imtm Gmbh |
Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
|
TW200613272A
(en)
|
2004-08-13 |
2006-05-01 |
Astrazeneca Ab |
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
|
|
WO2006038594A1
(ja)
*
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
Ｎ型カルシウムチャネル阻害薬
|
|
US8110681B2
(en)
|
2006-03-17 |
2012-02-07 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Compounds for the treatment of spinal muscular atrophy and other uses
|
|
RU2455302C2
(ru)
*
|
2006-12-27 |
2012-07-10 |
Санофи-Авентис |
ЗАМЕЩЕННЫЕ ИЗОХИНОЛИНОВЫЕ И ИЗОХИНОЛИНОНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Rho-КИНАЗЫ
|
|
US8394841B2
(en)
|
2007-02-22 |
2013-03-12 |
Irm Llc |
Compounds and methods for modulating G protein-coupled receptors
|
|
WO2009014100A1
(ja)
|
2007-07-20 |
2009-01-29 |
Chugai Seiyaku Kabushiki Kaisha |
ｐ２７蛋白質誘導剤
|
|
AU2009307656B2
(en)
*
|
2008-10-21 |
2015-07-02 |
Cymabay Therapeutics, Inc. |
Aryl GPR120 receptor agonists and uses thereof
|
|
AR074760A1
(es)
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
|
US8362052B2
(en)
|
2009-03-11 |
2013-01-29 |
Msd K.K. |
Isoindolin-1-one derivative
|
|
US8314120B2
(en)
|
2010-03-30 |
2012-11-20 |
Abbott Gmbh & Co. Kg |
Small molecule potentiators of metabotropic glutamate receptors
|
|
CA2801182A1
(en)
|
2010-06-16 |
2011-12-22 |
Metabolex, Inc. |
Gpr120 receptor agonists and uses thereof
|
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
|
TW201200505A
(en)
*
|
2010-06-17 |
2012-01-01 |
Metabolex Inc |
GPR120 receptor agonists and uses thereof
|
|
WO2013011402A1
(en)
|
2011-07-15 |
2013-01-24 |
Pfizer Inc. |
Gpr 119 modulators
|
|
AR088989A1
(es)
|
2011-11-30 |
2014-07-23 |
Hoffmann La Roche |
Derivados biciclicos de dihidroisoquinolin-1-ona
|
|
JP2015534948A
(ja)
|
2012-10-11 |
2015-12-07 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
Ｇｐｒ１２０アゴニストとして有用な置換スピロピペリジニル化合物
|
|
KR101942752B1
(ko)
|
2012-11-05 |
2019-01-28 |
주식회사 엘지화학 |
Ｇｐｒ120 효능제로서의 티오아릴 유도체
|
|
JP2016505550A
(ja)
*
|
2012-12-03 |
2016-02-25 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
置換トリアゾール及びイミダゾール化合物
|
|
EP2935257B1
(en)
|
2012-12-20 |
2018-02-07 |
Purdue Pharma LP |
Cyclic sulfonamides as sodium channel blockers
|
|
PL2970157T3
(pl)
*
|
2013-03-14 |
2019-02-28 |
Janssen Pharmaceutica Nv |
Benzo-skondensowane heterocykliczne pochodne przydatne jako agonisty gpr120
|
|
CA2905729C
(en)
|
2013-03-14 |
2021-11-09 |
Janssen Pharmaceutica Nv |
Bicyclic pyrrole derivatives useful as agonists of gpr120
|
|
EP3013796B9
(en)
|
2013-06-27 |
2020-07-01 |
LG Chem, Ltd. |
Biaryl derivatives as gpr120 agonists
|
|
AR099937A1
(es)
*
|
2014-04-04 |
2016-08-31 |
Sanofi Sa |
Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados
|
|
DK3140296T3
(en)
|
2014-05-07 |
2018-07-23 |
Bristol Myers Squibb Co |
PYRROLIDIN GPR40 MODULATORS FOR TREATMENT OF DISEASES SUCH AS DIABETES
|
|
DK3186241T3
(da)
|
2014-08-29 |
2021-01-11 |
Chdi Foundation Inc |
Prober til billeddannelse af huntington-protein
|
|
JP6486699B2
(ja)
|
2015-01-29 |
2019-03-20 |
国立大学法人金沢大学 |
脱水縮合剤
|
|
LT3365334T
(lt)
*
|
2015-10-21 |
2024-09-10 |
Otsuka Pharmaceutical Co., Ltd. |
Benzolaktamo junginiai kaip baltymų kinazės inhibitoriai
|
|
JP7065081B2
(ja)
*
|
2016-09-12 |
2022-05-11 |
インテグラル ヘルス， インコーポレイテッド |
Ｇｐｒ１２０モジュレーターとして有用な二環式化合物
|
|
CN110225752B
(zh)
*
|
2016-09-12 |
2023-05-05 |
整体健康 |
用作gpr120调节器的单环化合物
|